Veterinary Pain Management Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028

Veterinary Pain Management Market Size 2024-2028

The veterinary pain management market size is forecast to increase by USD 800.12 million, at a CAGR of 6.99% between 2023 and 2028.

• The market is experiencing significant growth, driven by the increasing trend of pet ownership. As the number of pets continues to rise, so does the demand for effective pain management solutions. This trend is further fueled by the growing recognition of pets as family members, leading pet owners to prioritize animal health and wellbeing. However, the market faces challenges in the form of limited awareness and education about veterinary pain management. Despite the availability of advanced pain management techniques, many pet owners and even some veterinarians are not fully informed about the importance of pain management in veterinary care.
• Additionally, the adoption of multimodal pain management approaches is increasing, requiring veterinary professionals to have a deep understanding of various pain management modalities and their applications. Navigating this complex landscape will require continued investment in education and training for veterinary staff and a focus on raising awareness among pet owners about the importance of pain management for their pets' quality of life.

What will be the Size of the Veterinary Pain Management Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.  
Request Free Sample

The market continues to evolve, driven by advancements in technology, research, and the increasing recognition of the importance of effective pain control in veterinary medicine. Feline pain management, cancer pain management, veterinary anesthesiology, postoperative pain management, orthopedic pain management, and adjunctive pain therapy are just a few areas where innovation is unfolding. Inflammatory mediators play a significant role in pain perception, leading to the development of new therapies for acute pain treatment. Spinal cord stimulation, patient-controlled analgesia (PCA), and regional anesthesia techniques are among the emerging solutions for managing various types of pain. Central sensitization, neuropathic pain relief, and multimodal analgesia are key areas of focus in veterinary pain management.

Opioid receptor antagonists and opioid alternatives are being explored as effective options for managing pain, especially in the context of chronic pain protocols. The use of pain assessment tools, such as veterinary pain scales, is becoming increasingly important for accurate diagnosis and treatment. NSAID pharmacology and dental pain management are also critical areas of research, with a focus on improving analgesic efficacy and minimizing side effects. Peripheral nerve blocks and local infiltration analgesia are essential techniques for managing pain in veterinary critical care settings. The ongoing development of new technologies and treatments is transforming the veterinary pain management landscape, offering new possibilities for improving animal welfare and enhancing the quality of veterinary care.

How is this Veterinary Pain Management Industry segmented?

The veterinary pain management industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Product
  • Drugs
  • Devices
• Distribution Channel
  • Veterinary hospitals
  • Pet care clinics
  • Pharmacy stores
• Geography
  • North America
    • US
  • Europe
    • Germany
    • UK
  • APAC
    • China
    • Japan
  • Rest of World (ROW)

By Product Insights

The drugs segment is estimated to witness significant growth during the forecast period.

The market encompasses a significant drugs segment, fueled by the rising awareness of animal welfare and the increasing prevalence of diseases causing discomfort in animals. This segment comprises pharmaceuticals like nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, and analgesics, which effectively alleviate pain in companion animals and livestock. For instance, carprofen, a popular NSAID for dogs, and meloxicam, which offers anti-inflammatory and analgesic properties, are widely used. The demand for species-specific medications and continuous research and development in veterinary pharmacology are expected to propel the growth of the drugs segment, thereby driving the expansion of the market.

This market also addresses various pain types, including acute and chronic, and targets different animal species, such as equine, feline, canine, and others. Techniques like patient-controlled analgesia (PCA), peripheral nerve blocks, and local infiltration analgesia are employed to manage pain effectively. Additionally, multimodal analgesia, which combines different pain relief methods, is gaining popularity. Inflammatory mediators play a crucial role in pain perception, and research on their mechanisms and potential therapeutic interventions is ongoing. Cancer pain management, neuropathic pain relief, and dental pain management are other significant areas of focus in veterinary pain management. Veterinary anesthesiology and postoperative pain management are essential components of veterinary care, with the latter employing techniques like opioid receptor antagonists and opioid alternatives to minimize pain.

Orthopedic pain management and adjunctive pain therapy are also essential, with the latter using anticonvulsant analgesics and chronic pain protocols. Central sensitization and nociceptive pathways are key concepts in understanding pain mechanisms and developing effective pain management strategies. Regional anesthesia techniques and local anesthetic techniques are employed to minimize pain during surgeries and veterinary critical care. The market is expected to grow substantially due to these trends and the increasing demand for effective pain relief solutions for animals.

Request Free Sample

The Drugs segment was valued at USD 1055.38 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

 Request Free Sample

The North American market is experiencing significant growth, driven by several key factors. With approximately 66% of US households owning a pet and over 86.9 million homes, the region's pet population is substantial. This expanding pet population, coupled with heightened awareness of animal welfare, fuels the demand for advanced pain management solutions. Veterinary clinics and hospitals are responding to this need by adopting innovative pain management techniques and technologies. Chronic illnesses in aging pets are another contributing factor, as they often require ongoing pain management. Industry events, such as those hosted by the North American Veterinary Community (NAVC), facilitate knowledge sharing and the adoption of the latest pain treatment innovations, further driving market expansion.

In veterinary medicine, various approaches are utilized for pain management, including spinal cord stimulation, patient-controlled analgesia (PCA), inflammatory mediator modulation, equine pain management, NSAID pharmacology, surgical pain control, pain assessment tools, acute pain treatment, feline pain management, cancer pain management, veterinary anesthesiology, postoperative pain management, orthopedic pain management, adjunctive pain therapy, peripheral nerve block, local infiltration analgesia, veterinary pain scales, central sensitization, multimodal analgesia, nociceptive pathways, neuropathic pain relief, dental pain management, regional anesthesia techniques, opioid receptor antagonists, opioid alternatives, canine pain management, local anesthetic techniques, veterinary critical care, analgesic efficacy, anticonvulsant analgesics, and chronic pain protocols. These methods aim to provide effective pain relief while minimizing potential side effects and ensuring the best possible patient outcomes.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in the adoption of Veterinary Pain Management Industry?

• The increasing trend of pet ownership is driving the market's growth by fostering the adoption of advanced veterinary pain management techniques. 

• The market is experiencing notable growth due to the rising number of pet-owning families worldwide. This trend is driven by changing lifestyles and increased concern for the health and well-being of companion animals. In the US alone, approximately 70% or 90.5 million families owned pets in 2021-22, signifying a significant increase in pet ownership. To address the pain management needs of these pets, advanced veterinary solutions are in high demand. Spinal cord stimulation and patient-controlled analgesia (PCA) are among the innovative pain management techniques gaining popularity. Inflammatory mediators play a crucial role in equine pain management, and a deep understanding of NSAID pharmacology is essential for effective surgical pain control.
• Pain assessment tools are increasingly being used to accurately diagnose and monitor pain in animals. Acute pain treatment is a critical aspect of veterinary care, and a comprehensive approach that considers both pharmacological and non-pharmacological interventions is emphasized. The market is expected to continue growing during the forecast period, as pet owners prioritize their animals' health and comfort.

What are the market trends shaping the Veterinary Pain Management Industry?

• The use of multimodal pain management approaches is gaining increasing popularity in the market. This trend involves the combination of different modalities, such as pharmacological, physical, and psychological interventions, to effectively manage pain and improve patient outcomes.

• The market is witnessing a notable shift towards multimodal pain management approaches, marking a significant evolution in the field. Veterinarians are adopting a holistic view of animal pain, combining various techniques such as medications, physical therapy, and complementary therapies. For instance, a dog undergoing orthopedic surgery may receive a combination of pain relievers, rehabilitation exercises, and acupuncture to manage both acute and chronic pain.
• This multidisciplinary approach caters to the unique pain experiences of animals, ensuring more effective and compassionate care. The increasing recognition of individual differences in animal pain perception is driving this trend, as veterinarians strive to provide personalized treatment plans that address pain from multiple angles.

What challenges does the Veterinary Pain Management Industry face during its growth?

• The lack of comprehensive awareness and education regarding veterinary pain management represents a significant challenge impeding industry expansion. 

• The market faces challenges in emerging economies due to limited awareness and understanding of animal pain indicators and the importance of proper pain management. In regions such as Southeast Asia and Africa, where pet ownership is rising, there is often a lack of knowledge regarding the impact of chronic pain on an animal's overall health. This results in underdiagnosis and undertreatment of pain disorders, hindering market growth. Veterinary specialists in these areas must educate pet owners on the significance of recognizing and treating animal pain, emphasizing the role of effective pain management in enhancing their pets' well-being and longevity.
• Central sensitization, neuropathic pain relief, multimodal analgesia, and regional anesthesia techniques are essential strategies for managing veterinary pain. Opioid receptor antagonists and nociceptive pathway modulation are also crucial components of veterinary pain management. Veterinary pain scales are valuable tools for assessing and monitoring animal pain levels, ensuring optimal treatment and improved patient outcomes.

Exclusive Customer Landscape

The veterinary pain management market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the veterinary pain management market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, veterinary pain management market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Assisi Animal Health - This company specializes in veterinary pain management using advanced Targeted Pulsed Electromagnetic Field (tPEMF) technology. 

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Assisi Animal Health
• Bimeda Holdings Ltd.
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Chanelle Pharma Group
• Dechra Pharmaceuticals Plc
• Durvet Animal Health Products
• Elanco Animal Health Inc.
• Manna Pro Products LLC
• Multi Radiance Medical
• Norbrook Laboratories Ltd.
• Vetoquinol SA
• Virbac Group
• Zoetis Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Veterinary Pain Management Market

• In January 2024, Zoetis, a leading animal health company, announced the launch of its new pain management product, Simparica Trixr, which combines the benefits of pain relief and flea and tick control in a single dose (Zoetis Press Release, 2024). In March 2024, Elanco Animal Health and Merck Animal Health formed a strategic partnership to co-develop and commercialize novel pain management solutions, aiming to expand their offerings and strengthen their market position (Elanco Animal Health Press Release, 2024).
• In April 2024, Heska Corporation, a veterinary diagnostics and software solutions provider, completed the acquisition of the pain management business unit of VetOne, expanding Heska's portfolio and enhancing its offerings in the market (Heska Corporation Press Release, 2024). In May 2025, the European Medicines Agency granted marketing authorization for Boehringer Ingelheim's new product, Rimadyl Oral Suspension, a pain reliever for dogs, expanding its availability in Europe and increasing competition in the region (Boehringer Ingelheim Press Release, 2025).

Research Analyst Overview

• The market is experiencing significant advancements, driven by the need for effective analgesic solutions for various animal species. Analgesic tolerance and recovery time reduction are key areas of focus, with research emphasizing pain score reduction and side effect profiling to enhance the efficacy of analgesic drug delivery. Pain behavior assessment and long-term pain management strategies are also gaining importance, as pharmacokinetic modeling and pharmacodynamic analysis contribute to improved mobility scores and behavioral indicators of pain. Clinical trial results and Therapeutic Drug Monitoring are essential for analgesic efficacy comparison, while veterinary neurology explores the complexities of pain management in animals.
• Osteoarthritis pain relief and symptom severity assessment are critical in veterinary medicine, with a growing emphasis on treatment compliance, drug interaction management, and dose-response relationships. Reduced inflammation levels and neuropathic pain diagnosis are also significant areas of research, as physiological pain markers provide valuable insights into the underlying mechanisms of animal pain. Overall, the market is evolving to address the unique challenges of managing pain in animals, with a focus on optimizing drug delivery, assessing pain behavior, and improving patient outcomes.

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Veterinary Pain Management Market insights. See full methodology.

Request Free Sample

What are the Key Data Covered in this Veterinary Pain Management Market Research and Growth Report?

• CAGR of the Veterinary Pain Management industry during the forecast period
• Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
• Accurate predictions about upcoming growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the veterinary pain management market growth of industry companies

We can help! Our analysts can customize this veterinary pain management market research report to meet your requirements.

Get in touch